Device Trial Radar · NCT02878590
Clinical Study for the BONGO Device in the Treatment of Obstructive Sleep Apnea (OSA)
Last checked: Nov 21, 2026Latest source record: Feb 19, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
23
Actual
Start
Sep 2016
Primary completion
Nov 30, 2017
Study completion Nov 30, 2017
Sponsor
- Lead sponsor
- InnoMed Healthscience Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- RVW Clinical Consulting
- First posted
- Aug 25, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective, non-randomized, open label study
Conditions
- Obstructive Sleep Apnea
Interventions
BONGO DEVICEDevice
A device to be used for the treatment of mild to moderate obstructive sleep apnea
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Apnea-Hypopnea Index (AHI)Time frame: At Diagnostic Baseline PSG and at Final Treatment PSG with the device
Locations
1 site in 1 country. Site status is shown where the registry gives one.
California Center for Sleep Disorders
Alameda, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.